Song Tae Jun, Kim Myung-Hwan, Kim Min Jae, Moon Sung Hoon, Han Ji Min
Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Pancreatology. 2014 Jul-Aug;14(4):233-7. doi: 10.1016/j.pan.2014.04.033. Epub 2014 May 10.
There have been great developments in the diagnosis and treatment of autoimmune pancreatitis (AIP) in the last decade. Most significantly, the international consensus diagnostic criteria (ICDC) proposed in 2011 were the first attempt to provide unified diagnostic criteria incorporating most features of the previously existing national criteria. However, the ICDC have not yet been prospectively validated using evidence-based studies since their introduction. An international symposium on the diagnosis of AIP was held in Seoul, South Korea on September 6, 2013, in cooperation with the International Association of Pancreatology and the Korean Pancreatobiliary Association meeting. In contrast to other symposia in the past, which had primarily focused on the diagnostic criteria themselves, expert panels in this symposium discussed how the diagnostic criteria and algorithms had been embraced in clinical settings to diagnose AIP in each country and conducted a comprehensive evaluation of these criteria and algorithms. It was acknowledged that there was a room for improvement in the ICDC and their algorithms and that further modifications might be required in the future. Prospective clinical validation in larger series is needed for confirmation.
在过去十年中,自身免疫性胰腺炎(AIP)的诊断和治疗取得了重大进展。最显著的是,2011年提出的国际共识诊断标准(ICDC)首次尝试提供统一的诊断标准,纳入了先前各国标准的大多数特征。然而,自引入以来,ICDC尚未通过循证研究进行前瞻性验证。2013年9月6日,与国际胰腺病协会和韩国胰胆协会会议合作,在韩国首尔举行了一次关于AIP诊断的国际研讨会。与过去主要关注诊断标准本身的其他研讨会不同,本次研讨会的专家小组讨论了各国在临床环境中如何采用诊断标准和算法来诊断AIP,并对这些标准和算法进行了全面评估。人们认识到ICDC及其算法仍有改进空间,未来可能需要进一步修改。需要通过更大规模的前瞻性临床验证来确认。